Genpact (G) EBITDA (2009 - 2026)

Genpact's EBITDA history runs 18 years deep, the most recent figure standing at $198.6 million for Q1 2026.

• On a quarterly basis, EBITDA rose 8.1% year-over-year to $198.6 million in Q1 2026; TTM through Mar 2026 was $765.1 million, a 5.42% increase from a year earlier, with the FY2025 full-year figure at $750.2 million, up 6.86% from the prior year.
• EBITDA rose to $198.6 million in Q1 2026 per G's latest filing, from $195.5 million in the prior quarter.
• Across five years, EBITDA topped out at $198.6 million in Q1 2026 and bottomed at $109.7 million in Q2 2022.
• The 5-year median for EBITDA is $165.7 million (2023), against an average of $163.8 million.
• Across the five-year window, EBITDA decreased 19.88% in 2022 and jumped 43.43% in 2023, its largest moves.
• Year by year, EBITDA stood at $127.8 million in 2022, then grew by 27.38% to $162.7 million in 2023, then grew by 16.86% to $190.2 million in 2024, then advanced by 2.78% to $195.5 million in 2025, then grew by 1.6% to $198.6 million in 2026.
• Per Business Quant, the three latest G EBITDA figures stand at $198.6 million (Q1 2026), $195.5 million (Q4 2025), and $191.6 million (Q3 2025).